Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RCUS

Arcus Biosciences, Inc.

CIK 0001724521 · NYSE

NYSEHealth CarePharmaceutical Preparations
$30.34
↑ 0.82 (2.78%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$3.86B
P/E Ratio
-8.40
EPS
-3.29
Dividend Yield
Not covered
52W Position
94%
Beta
1.77

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
8.33
P/S
33.02
EV/Revenue
32.60
ROE
-99.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 94%
$9.92$31.73

Latest Financials

2025-12-31 FY
Revenue
$247.00M
Net Income
-$353.00M
Total Assets
$1.14B
Free Cash Flow
-$484.00M

Recent news